Oscar Health (OSCR) Price Target Increased by 20.38% to 19.93
UBS Maintains Neutral on Oscar Health, Raises Price Target to $20
Barclays Maintains Equal-Weight on Oscar Health, Raises Price Target to $21
Baird Maintains Neutral on Oscar Health, Raises Price Target to $19
Wolfe Research Initiates Coverage of Oscar Health (OSCR) with Peer Perform Recommendation
Oscar Health, Inc. (OSCR) Q1 2026 Earnings Call Transcript
Wolfe Research Initiates Coverage On Oscar Health with Peer Perform Rating
Oscar Health (NYSE:OSCR) Surges on Earnings Beat Despite Revenue Shortfall
Oscar Health Earnings Review: The Best Q1 Scenario We Could Hope For
Full Transcript: Oscar Health Q1 2026 Earnings Call
Oscar Health Affirms FY2026 Sales Guidance of $18.700B-$19.000B vs $18.802B Est
Oscar Health Q1 EPS $2.07 Beats $1.01 Estimate, Sales $4.647B Miss $4.916B Estimate
Oscar Health Appoints Siddhartha Sankaran As Chair Of The Board, Effective June 4, Succeeding Jeffery Boyd
Jefferies Upgrades Oscar Health (OSCR)
Jefferies Upgrades Oscar Health to Hold, Raises Price Target to $16
Oscar Health Launches Lucie Health Marketplace To Connect Consumers And Brokers To Every Major Individual Market Plan And Establish A Curated Menu Of Ancillary And Supplemental Products
Oscar Health At A Crossroads: A Credibility‑Based Stock Facing An Explode‑Or‑Sink Setup
Oscar Health: A High-Growth Story With Significant Re-Rating Potential
Oscar Health Stock Jumps After CEO Buys $11.92 Million In Shares
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.